Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAE Systems Regulatory News (BA.)

Share Price Information for BAE Systems (BA.)

Share Price is delayed by 15 minutes
Get Live Data
1,933.50    -16.50 (-0.85%)
Bid:
1,929.50
Ask:
1,930.00
Spread: 0.50 (0.026%)
Market Cap: £56.73b
BA. Live PriceLast checked at - London Stock Exchange

Intraday BAE Systems Share Chart

Share Buyback Programme Update

1 Jun 2023 08:00

RNS Number : 2519B
BAE SYSTEMS PLC
01 June 2023
 

 

1 June 2023

BAE Systems plc

 

BAE Systems Initiates £500million Third Tranche of Share Buyback Programme

 

Today, BAE Systems plc ("BAE Systems", or the "Company") announces that it has entered into an arrangement with Morgan Stanley & Co. International plc ("Morgan Stanley") in relation to the third tranche (the "Third Tranche") of the share buyback programme announced by the Company on 28 July 2022 (the "Buyback Programme"). The First and Second Tranches of the Buyback Programme completed on 16 November 2022 and 16 May 2023 respectively. The sole purpose of the Buyback Programme is to reduce the issued share capital of the Company.

 

In connection with the Third Tranche, the Company has instructed Morgan Stanley, acting as riskless principal, to purchase ordinary shares of BAE Systems (the "Shares") for an amount of up to £500 million. The Third Tranche will run from and including 1 June 2023 and is expected to be completed by 24 July 2024.

 

Any purchases of Shares under the Third Tranche will be effected within certain pre-set parameters. These arrangements are in accordance with BAE Systems' general authority to repurchase Shares granted at its Annual General Meeting held on 4 May 2023 (the "2023 AGM"), Chapter 12 of the Listing Rules, and those provisions of Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) dealing with buyback programmes. The number of ordinary shares to be purchased under the Buyback Programme will not exceed 305,567,916 Shares and is therefore within the 2023 AGM approved limit.

 

Details of the authority granted at the 2023 AGM can be found on our website under: https://investors.baesystems.com/~/media/Files/B/Bae-Systems-Investor-Relations-V3/PDFs/results-and-reports/results/2022/agm-notice-of-meeting-2023.pdf

 

 

For further information, please contact:

Investors

Media

Martin Cooper,

Investor Relations Director

Telephone: +44 (0)1252 383455

Email: investors@baesystems.com

Kristina Anderson,

Director, Media Relations

Telephone: +44 (0) 7540 628673

Email: Kristina.anderson@baesystems.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVFLFXXELFBBX
Date   Source Headline
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSFinal Results
18th Feb 20252:10 pmRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20252:05 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 202511:00 amRNSDirector Declaration
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20254:47 pmRNSDirector/PDMR Shareholding
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20241:00 pmRNSTotal Voting Rights
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.